I.M.D. International Medical Devices S.p.A.

BIT:IMD Stock Report

Market Cap: €25.6m

I.M.D. International Medical Devices Valuation

Is IMD undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of IMD when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: IMD (€1.46) is trading below our estimate of fair value (€2.4)

Significantly Below Fair Value: IMD is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for IMD?

Key metric: As IMD is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for IMD. This is calculated by dividing IMD's market cap by their current earnings.
What is IMD's PE Ratio?
PE Ratio9.8x
Earnings€2.58m
Market Cap€25.64m

Price to Earnings Ratio vs Peers

How does IMD's PE Ratio compare to its peers?

The above table shows the PE ratio for IMD vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average10x
ELN EL.En
19x8.3%€982.4m
SVS Svas Biosana
6.9x13.0%€37.0m
IVN iVision Tech
0.02x-111.5%€14.0m
HI Health Italia
14.2xn/a€24.6m
IMD I.M.D. International Medical Devices
9.8x18.6%€25.6m

Price-To-Earnings vs Peers: IMD is good value based on its Price-To-Earnings Ratio (9.8x) compared to the peer average (10x).

Price to Earnings Ratio vs Industry

How does IMD's PE Ratio compare vs other companies in the European Medical Equipment Industry?

3 CompaniesPrice / EarningsEstimated GrowthMarket Cap
IMD 9.8xIndustry Avg. 28.2xNo. of Companies7PE01632486480+
3 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: IMD is good value based on its Price-To-Earnings Ratio (9.8x) compared to the European Medical Equipment industry average (28.2x).

Price to Earnings Ratio vs Fair Ratio

What is IMD's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

IMD PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio9.8x
Fair PE Ratio14.8x

Price-To-Earnings vs Fair Ratio: IMD is good value based on its Price-To-Earnings Ratio (9.8x) compared to the estimated Fair Price-To-Earnings Ratio (14.8x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst IMD forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€1.46
€2.14
+46.6%
15.9%€2.48€1.80n/a2
Nov ’25€1.59
€2.14
+34.6%
15.9%€2.48€1.80n/a2
Oct ’25€1.49
€2.13
+42.6%
15.3%€2.45€1.80n/a2
Sep ’25€1.36
€2.40
+76.5%
2.1%€2.45€2.35n/a2
Aug ’25€1.29
€2.40
+86.0%
2.1%€2.45€2.35n/a2
Jul ’25€1.40
€2.40
+71.4%
2.1%€2.45€2.35n/a2
Jun ’25€1.44
€2.40
+66.7%
2.1%€2.45€2.35n/a2
May ’25€1.52
€2.40
+57.9%
2.1%€2.45€2.35n/a2
Apr ’25€1.41
€2.40
+70.2%
2.1%€2.45€2.35n/a2
Mar ’25€1.45
€2.40
+65.5%
2.1%€2.45€2.35n/a2
Feb ’25€1.71
€2.40
+40.8%
2.1%€2.45€2.35n/a2
Jan ’25€1.76
€2.40
+36.8%
2.1%€2.45€2.35n/a2
Dec ’24€1.76
€2.40
+36.4%
2.1%€2.45€2.35n/a2
Nov ’24€1.84
€2.60
+41.3%
5.8%€2.75€2.45€1.592

Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.

Discover undervalued companies

Fresenius Medical Care

€12.2b

Provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally.

1FME

€41.39

7D

1.4%

1Y

15.5%

Amplifon

€5.2b

Engages in the distribution of hearing solutions and the fitting of customized products that help people rediscover various emotions of sound in Europe, the Middle East, Africa, the Americas, and the Asia Pacific.

AMP

€23.26

7D

-3.1%

1Y

-17.7%

Garofalo Health Care

€517.2m

Operates healthcare clinics in Italy.

GHC

€5.84

7D

2.1%

1Y

30.6%